Markets:

Overview

News

Currencies

International

Treasuries

Taysha Gene Therapies, Inc. - Common Stock (NQ:TSHA)

6.435 -0.125 (-1.91%)

Streaming Delayed Price Updated: 3:19 PM EDT, Aug 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Taysha Gene Therapies, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Expert Outlook: Taysha Gene Therapies Through The Eyes Of 7 Analysts ↗

November 15, 2024

Via Benzinga

Hillenbrand Posts Better-Than-Expected Earnings, Joins Beazer Homes, Tapestry, Walt Disney And Other Big Stocks Moving Higher On Thursday ↗

November 14, 2024

Via Benzinga

Advance Auto Parts Posts Weak Results, Joins Harrow, Taysha Gene Therapies And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗

November 14, 2024

Via Benzinga

Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?"

November 14, 2024

Neurogene has been on a huge run in 2024. That came to a halt after the company released trial results. But, the results may be better than the market thinks.

Via MarketBeat

Earnings Scheduled For November 13, 2024 ↗

November 13, 2024

Via Benzinga

Preview: Taysha Gene Therapies's Earnings ↗

November 12, 2024

Via Benzinga

Peeling Back The Layers: Exploring Taysha Gene Therapies Through Analyst Insights ↗

August 12, 2024

Via Benzinga

Where Taysha Gene Therapies Stands With Analysts ↗

July 23, 2024

Via Benzinga

Why DLocal Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗

November 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 12, 2024

Via Benzinga

Dow Dips Over 200 Points; Home Depot Posts Upbeat Earnings ↗

November 12, 2024

Via Benzinga

Topics Stocks

Tyson Foods Posts Better-Than-Expected Earnings, Joins Shopify, Sea, Buckle And Other Big Stocks Moving Higher On Tuesday ↗

November 12, 2024

Via Benzinga

The Analyst Landscape: 16 Takes On Taysha Gene Therapies ↗

June 17, 2024

Via Benzinga

Breaking Down Taysha Gene Therapies: 16 Analysts Share Their Views ↗

May 28, 2024

Via Benzinga

11 Analysts Assess Taysha Gene Therapies: What You Need To Know ↗

April 30, 2024

Via Benzinga

Why Grab Holdings Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket ↗

November 12, 2024

Via Benzinga

TSHA Stock Earnings: Taysha Gene Therapies Beats EPS, Misses Revenue for Q2 2024 ↗

August 12, 2024

TSHA stock results show that Taysha Gene Therapies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

Via InvestorPlace

Why Is Taysha Gene Therapies (TSHA) Stock Down 14% Today? ↗

June 26, 2024

Taysha Gene Therapies stock is down on Wednesday after the company announced a proposed public offering for TSHA shares.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

June 26, 2024

It's time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning!

Via InvestorPlace

Worthington Enterprises Posts Downbeat Results, Joins Taysha Gene Therapies, General Mills And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

June 26, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 19, 2024

Via Benzinga

S&P 500 Edges Higher; America's Car-Mart Shares Tumble After Q4 Earnings ↗

June 18, 2024

Via Benzinga

Topics Stocks

Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

June 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 18, 2024

Via Benzinga

Crude Oil Rises 1%; DermTech Shares Plummet ↗

June 18, 2024

Via Benzinga

What's Going On With Taysha Gene Therapies Stock Tuesday? ↗

June 18, 2024

Taysha Gene Therapies reveals promising longer-term and initial clinical data from their REVEAL Phase 1/2 trials evaluating TSHA-102 for Rett syndrome.

Via Benzinga

TSHA Stock Earnings: Taysha Gene Therapies Beats EPS, Beats Revenue for Q1 2024 ↗

May 14, 2024

TSHA stock results show that Taysha Gene Therapies beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

April 12, 2024

U.S. stock futures were mixed this morning, with the Dow futures gaining over 50 points on Friday.

Via Benzinga

Topics Stocks

Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday ↗

April 10, 2024

U.S. stocks were lower, with the Dow Jones index falling over 300 points on Wednesday.

Via Benzinga

Topics Stocks

Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 09, 2024

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.